341
Views
0
CrossRef citations to date
0
Altmetric
Research Article

High-dimensional propensity score and its machine learning extensions in residual confounding control

ORCID Icon
Received 14 Nov 2023, Accepted 03 Jun 2024, Accepted author version posted online: 17 Jun 2024
Accepted author version

References

  • Afzal, Zubair, Gwen MC Masclee, Miriam CJM Sturkenboom, Jan A Kors, and Martijn J Schuemie. 2019. “Generating and evaluating a propensity model using textual features from electronic medical records.” Plos one 14 (3): e0212999.
  • Ahrens, A, CB Hansen, ME Schaffer, and T Wiemann. 2023. “ddml: Double/debiased machine learning in Stata.” arXiv preprint arXiv:2301.09397 .
  • Atems, Bebonchu, and Jason Bergtold. 2016. “Revisiting the statistical specification of near-multicollinearity in the logistic regression model.” Studies in Nonlinear Dynamics & Econometrics 20 (2): 199–210.
  • Austin, Peter C, Nathaniel Jembere, and Maria Chiu. 2018. “Propensity score matching and complex surveys.” Statistical methods in medical research 27 (4): 1240–1257.
  • Austin, Peter C, and Elizabeth A Stuart. 2015. “Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.” Statistics in medicine 34 (28): 3661–3679.
  • Austin, Steven R, Yu-Ning Wong, Robert G Uzzo, J Robert Beck, and Brian L Egleston. 2015. “Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work.” Medical care 53 (9): e65.
  • Balzer, Laura B, and Ted Westling. 2023. “Demystifying statistical inference when using machine learning in causal research.” American Journal of Epidemiology 192 (9): 1545–1549.
  • Benasseur, Imane, Denis Talbot, Madeleine Durand, Anne Holbrook, Alexis Matteau, Brian J Potter, Christel Renoux, Mireille E Schnitzer, Jean-Éric Tarride, and Jason R Guertin. 2022. “A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.” Pharmacoepidemiology and Drug Safety 31 (4): 424–433.
  • Brookhart, M Alan, Jeremy A Rassen, and Sebastian Schneeweiss. 2010. “Instrumental variable methods in comparative safety and effectiveness research.” Pharmacoepidemiology and drug safety 19 (6): 537–554.
  • Brookhart, M Alan, Sebastian Schneeweiss, Kenneth J Rothman, Robert J Glynn, Jerry Avorn, and Til Stürmer. 2006. “Variable selection for propensity score models.” American journal of epidemiology 163 (12): 1149–1156.
  • Bross, Irwin DJ. 1966. “Spurious effects from an extraneous variable.” Journal of chronic diseases 19 (6): 637–647.
  • Charlson, Mary E, Peter Pompei, Kathy L Ales, and C Ronald MacKenzie. 1987. “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.” Journal of chronic diseases 40 (5): 373–383.
  • Cheng, David, Abhishek Chakrabortty, Ashwin N Ananthakrishnan, and Tianxi Cai. 2020. “Estimating average treatment effects with a double-index propensity score.” Biometrics 76 (3): 767–777.
  • Chernozhukov, V, D Chetverikov, M Demirer, E Duflo, C Hansen, W Newey, and J Robins. 2018. “Double/debiased machine learning for treatment and structural parameters.” The Econometrics Journal 21: 1–68.
  • Choi, BCK, and F Shi. 2001. “Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey.” Diabetologia 44: 1221–1231.
  • Connolly, John G, Sebastian Schneeweiss, Robert J Glynn, and Joshua J Gagne. 2019. “Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.” Pharmacoepidemiology and drug safety 28 (5): 665–670.
  • Dorn, Jacob, and Kevin Guo. 2023. “Sharp sensitivity analysis for inverse propensity weighting via quantile balancing.” Journal of the American Statistical Association 118 (544): 2645–2657.
  • DuGoff, Eva H, Megan Schuler, and Elizabeth A Stuart. 2014. “Generalizing observational study results: applying propensity score methods to complex surveys.” Health services research 49 (1): 284–303.
  • Elixhauser, Anne, Claudia Steiner, D Robert Harris, and Rosanna M Coffey. 1998. “Comorbidity measures for use with administrative data.” Medical care 8–27.
  • Enders, Dirk, Christoph Ohlmeier, and Edeltraut Garbe. 2018. “The potential of high-dimensional propensity scores in health services research: an exemplary study on the quality of Care for Elective Percutaneous Coronary Interventions.” Health services research 53 (1): 197–213.
  • Farley, Joel F, Carolyn R Harley, and Joshua W Devine. 2006. “A comparison of comorbidity measurements to predict healthcare expenditures.” American Journal of Managed Care 12 (2): 110–118.
  • for Disease Control, Centers, and Prevention. 2021. “National Health and Nutrition Examination Survey (NHANES).” National Center for Health Statistics Accessed: April 20, 2023.
  • Franklin, Jessica M, Wesley Eddings, Robert J Glynn, and Sebastian Schneeweiss. 2015. “Regularized regression versus the high-dimensional propensity score for confounding adjustment in secondary database analyses.” American journal of epidemiology 182 (7): 651–659.
  • Friedman, Jerome, Trevor Hastie, and Rob Tibshirani. 2010. “Regularization paths for generalized linear models via coordinate descent.” Journal of statistical software 33 (1): 1.
  • Friedman, Jerome H. 1991. “Multivariate adaptive regression splines.” The annals of statistics 19 (1): 1–67.
  • Greenland, Sander, Judea Pearl, and James M Robins. 1999. “Causal diagrams for epidemiologic research.” Epidemiology 37–48.
  • Greifer, Noah. 2022. “WeightIt: Weighting for Covariate Balance in Observational Studies.” Online. R package version 0.13.1, https://CRAN.R-project.org/package=WeightIt.
  • Gruber, Susan, and Mark J. van der Laan. 2012. “tmle: An R Package for Targeted Maximum Likelihood Estimation.” Journal of Statistical Software 51 (13): 1–35. DOI: 10.18637/jss.v051.i13,.https://www.jstatsoft.org/v51/i13/.
  • Hardy, Olga T, Michael P Czech, and Silvia Corvera. 2012. “What causes the insulin resistance underlying obesity?” Current opinion in endocrinology, diabetes, and obesity 19 (2): 81.
  • Hernán, Miguel A., and James M. Robins. 2023. Causal Inference: What If . 1st ed. Boca Raton: Chapman & Hall/CRC.
  • Hernán, Miguel A, and Sarah L Taubman. 2008. “Does obesity shorten life? The importance of well-defined interventions to answer causal questions.” International journal of obesity 32 (3): S8–S14.
  • Hirsch, JA, G Nicola, G McGinty, RW Liu, RM Barr, MD Chittle, and L Manchikanti. 2016. “ICD-10: history and context.” American Journal of Neuroradiology 37 (4): 596–599.
  • Ho, Daniel E, Kosuke Imai, Gary King, and Elizabeth A Stuart. 2007. “Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.” Political analysis 15 (3): 199–236.
  • Ju, Cheng, David Benkeser, and Mark J van Der Laan. 2020. “Robust inference on the average treatment effect using the outcome highly adaptive lasso.” Biometrics 76 (1): 109–118.
  • Ju, Cheng, Mary Combs, Samuel D Lendle, Jessica M Franklin, Richard Wyss, Sebastian Schneeweiss, and Mark J van der Laan. 2019a. “Propensity score prediction for electronic healthcare databases using super learner and high-dimensional propensity score methods.” Journal of Applied Statistics 46 (12): 2216–2236.
  • Ju, Cheng, Susan Gruber, Samuel D Lendle, Antoine Chambaz, Jessica M Franklin, Richard Wyss, Sebastian Schneeweiss, and Mark J van Der Laan. 2019b. “Scalable collaborative targeted learning for high-dimensional data.” Statistical methods in medical research 28 (2): 532–554.
  • Ju, Cheng, Richard Wyss, Jessica M Franklin, Sebastian Schneeweiss, Jenny Häggström, and Mark J van der Laan. 2019c. “Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data.” Statistical methods in medical research 28 (4): 1044–1063.
  • Judkins, David R, David Morganstein, Paul Zador, Andrea Piesse, Brandon Barrett, and Pushpal Mukhopadhyay. 2007. “Variable selection and raking in propensity scoring.” Statistics in medicine 26 (5): 1022–1033.
  • Kabadi, Shaum M, Brian K Lee, and Longjian Liu. 2012. “Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001–2006.” Diabetes care 35 (10): 2048–2054.
  • Karim, M. E. 2023a. “High-dimensional propensity score and its machine learning extensions in residual confounding control in pharmacoepidemiologic studies.” Zenodo, DOI: 10.5281/zenodo.7877767,.https://ehsanx.github.io/hdPS/. http://dx.doi.org/10.5281/zenodo.7877767.
  • Karim, ME. 2023b. “Advanced Epidemiological Methods.” Online. https://ehsanx.github.io/EpiMethods/, https://ehsanx.github.io/EpiMethods/.
  • Karim, ME. 2023c. “Rethinking Residual Confounding Bias Reduction: Why Vanilla hdPS Alone is No Longer Enough.” https://ehsanx.github.io/hdPS/, April.
  • Karim, ME, M Pang, and RW Platt. 2018. “Can we train machine learning methods to outperform the high-dimensional propensity score algorithm?” Epidemiology 29 (2): 191–198.
  • Karim, ME, F Pellegrini, RW Platt, G Simoneau, J Rouette, and C de Moor. 2022. “The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review.” Multiple Sclerosis Journal 28 (9): 1317–1323.
  • Klein, Samuel, Amalia Gastaldelli, Hannele Yki-Järvinen, and Philipp E Scherer. 2022. “Why does obesity cause diabetes?” Cell metabolism 34 (1): 11–20.
  • Kong, Alice PS, Gang Xu, Nicola Brown, Wing-Yee So, Ronald CW Ma, and Juliana CN Chan. 2013. “Diabetes and its comorbidities—where East meets West.” Nature Reviews Endocrinology 9 (9): 537–547.
  • Liu, Jian, John Hay, Brent E Faught, et al. 2013. “The association of sleep disorder, obesity status, and diabetes mellitus among US adults—The NHANES 2009-2010 survey results.” International journal of endocrinology 2013.
  • Lix, Lisa M, Jacqueline Quail, Opeyemi Fadahunsi, and Gary F Teare. 2013. “Predictive performance of comorbidity measures in administrative databases for diabetes cohorts.” BMC Health Services Research 13: 1–12.
  • Lix, LM, J Quail, G Teare, and B Acan. 2011. “Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts.” Osteoporosis international 22: 2633–2643.
  • Longarela, A, J Olarra, L Suarez, and A Garcia de Lorenzo. 2000. “Metabolic response to stress, can we control it?” Nutrición hospitalaria 15 (6): 275–279.
  • Low, Yen Sia, Blanca Gallego, and Nigam Haresh Shah. 2016. “Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records.” Journal of comparative effectiveness research 5 (2): 179–192.
  • Malone, Margaret. 2005. “Medications associated with weight gain.” Annals of Pharmacotherapy 39 (12): 2046–2055.
  • McIntyre, H David, Patrick Catalano, Cuilin Zhang, Gernot Desoye, Elisabeth R Mathiesen, and Peter Damm. 2019. “Gestational diabetes mellitus.” Nature reviews Disease primers 5 (1): 47.
  • Mondol, MH, and ME Karim. 2023. “Crossfit: An R package to apply sample splitting (cross-fit) to AIPW and TMLE in causal inference.” https://github.com/momenulhaque/Crossfit.
  • Myers, Jessica A, Jeremy A Rassen, Joshua J Gagne, Krista F Huybrechts, Sebastian Schneeweiss, Kenneth J Rothman, Marshall M Joffe, and Robert J Glynn. 2011. “Effects of adjusting for instrumental variables on bias and precision of effect estimates.” American journal of epidemiology 174 (11): 1213–1222.
  • Naimi, Ashley I, and Laura B Balzer. 2018. “Stacked generalization: an introduction to super learning.” European journal of epidemiology 33: 459–464.
  • Naimi, Ashley I, Alan E Mishler, and Edward H Kennedy. 2023. “Challenges in obtaining valid causal effect estimates with machine learning algorithms.” American Journal of Epidemiology 192 (9): 1536–1544.
  • Naimi, Ashley I, and Brian W Whitcomb. 2020. “Estimating risk ratios and risk differences using regression.” American journal of epidemiology 189 (6): 508–510.
  • Neugebauer, Romain, Julie A Schmittdiel, Zheng Zhu, Jeremy A Rassen, John D Seeger, and Sebastian Schneeweiss. 2015. “High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.” Statistics in medicine 34 (5): 753–781.
  • Newey, WK, and JR Robins. 2018. “Cross-fitting and fast remainder rates for semiparametric estimation.” arXiv preprint arXiv:1801.09138 .
  • Normand, Sharon-Lise T, Mary Beth Landrum, Edward Guadagnoli, John Z Ayanian, Thomas J Ryan, Paul D Cleary, and Barbara J McNeil. 2001. “Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.” Journal of clinical epidemiology 54 (4): 387–398.
  • Ogundimu, Emmanuel O. 2019. “Prediction of default probability by using statistical models for rare events.” Journal of the Royal Statistical Society Series A: Statistics in Society 182 (4): 1143–1162.
  • Ostchega, Yechiam, Jeffery P Hughes, Ana Terry, Tala HI Fakhouri, and Ivey Miller. 2012. “Abdominal obesity, body mass index, and hypertension in US adults: NHANES 2007–2010.” American journal of hypertension 25 (12): 1271–1278.
  • Pang, Menglan, Tibor Schuster, Kristian B Filion, Maria Eberg, and Robert W Platt. 2016a. “Targeted maximum likelihood estimation for pharmacoepidemiologic research.” Epidemiology (Cambridge, Mass.) 27 (4): 570.
  • Pang, Menglan, Tibor Schuster, Kristian B Filion, Mireille E Schnitzer, Maria Eberg, and Robert W Platt. 2016b. “Effect estimation in point-exposure studies with binary outcomes and high-dimensional covariate data–a comparison of targeted maximum likelihood estimation and inverse probability of treatment weighting.” The international journal of biostatistics 12 (2).
  • Patrick, Amanda R, Sebastian Schneeweiss, M Alan Brookhart, Robert J Glynn, Kenneth J Rothman, Jerry Avorn, and Til Stürmer. 2011. “The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.” Pharmacoepidemiology and drug safety 20 (6): 551–559.
  • Petersen, Maya L, Kristin E Porter, Susan Gruber, Yue Wang, and Mark J Van Der Laan. 2012. “Diagnosing and responding to violations in the positivity assumption.” Statistical methods in medical research 21 (1): 31–54.
  • Phillips, Rachael V, Mark J van der Laan, Hana Lee, and Susan Gruber. 2023. “Practical considerations for specifying a super learner.” International Journal of Epidemiology 52 (4): 1276–1285.
  • Pirracchio, Romain, Maya L Petersen, and Mark Van Der Laan. 2015. “Improving propensity score estimators’ robustness to model misspecification using super learner.” American journal of epidemiology 181 (2): 108–119.
  • Platt, RW, ME Karim, TPA Debray, M Copetti, G Tsivgoulis, E Waubant, and H Hartung. 2019. “Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis: when methodology does not hold the promise.” Journal of Neurology, Neurosurgery, and Psychiatry 90 (4): 458.responses. https://jnnp.bmj.com/content/90/4/458.responses.
  • Polley, Eric, Erin LeDell, Chris Kennedy, and Mark van der Laan. 2023. “SuperLearner: Super Learner Prediction.” Online. R package version 2.0-28.1, https://CRAN.R-project.org/package=SuperLearner.
  • Rassen, Jeffrey A., Michael Doherty, Wenshan Huang, and Sebastian Schneeweiss. 2023a. “Pharmacoepidemiology Toolbox.” Online: https://www.drugepi.org/dope/software. Oct 23, http://www.hdpharmacoepi.org.
  • Rassen, Jeremy A, Patrick Blin, Sebastian Kloss, Romain S Neugebauer, Robert W Platt, Anton Pottegård, Sebastian Schneeweiss, and Sengwee Toh. 2023b. “High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.” Pharmacoepidemiology and Drug Safety 32 (2): 93–106.
  • Robert, Dennis. 2020. “autoCovariateSelection: Automatic Covariate Selection.” Online. R package version 1.0.0, https://CRAN.R-project.org/package=autoCovariateSelection.
  • Robins, James M, and Andrea Rotnitzky. 1995. “Semiparametric efficiency in multivariate regression models with missing data.” Journal of the American Statistical Association 90 (429): 122–129.
  • Rose, Sherri. 2013. “Mortality risk score prediction in an elderly population using machine learning.” American journal of epidemiology 177 (5): 443–452.
  • Rosenbaum, Paul R, and Donald B Rubin. 1983. “The central role of the propensity score in observational studies for causal effects.” Biometrika 70 (1): 41–55.
  • Rubin, Donald B. 1997. “Estimating causal effects from large data sets using propensity scores.” Annals of internal medicine 127 (8_Part_2): 757–763.
  • Rubin, Donald B. 2001. “Using propensity scores to help design observational studies: application to the tobacco litigation.” Health Services and Outcomes Research Methodology 2: 169–188.
  • Rubin, Donald B, and Neal Thomas. 1996. “Matching using estimated propensity scores: relating theory to practice.” Biometrics 249–264.
  • Saydah, Sharon, Kai McKeever Bullard, Yiling Cheng, Mohammed K Ali, Edward W Gregg, Linda Geiss, and Giuseppina Imperatore. 2014. “Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999-2010.” Obesity 22 (8): 1888–1895.
  • Schneeweiss, Sebastian. 2006. “Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.” Pharmacoepidemiology and drug safety 15 (5): 291–303.
  • Schneeweiss, Sebastian. 2018. “Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.” Clinical epidemiology 771–788.
  • Schneeweiss, Sebastian, Wesley Eddings, Robert J Glynn, Elisabetta Patorno, Jeremy Rassen, and Jessica M Franklin. 2017. “Variable selection for confounding adjustment in high-dimensional covariate spaces when analyzing healthcare databases.” Epidemiology 28 (2): 237–248.
  • Schneeweiss, Sebastian, and Malcolm Maclure. 2000. “Use of comorbidity scores for control of confounding in studies using administrative databases.” International journal of epidemiology 29 (5): 891–898.
  • Schneeweiss, Sebastian, Jeremy A Rassen, Robert J Glynn, Jerry Avorn, Helen Mogun, and M Alan Brookhart. 2009. “High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.” Epidemiology (Cambridge, Mass.) 20 (4): 512.
  • Schuster, Tibor, Wilfrid Kouokam Lowe, and Robert W Platt. 2016. “Propensity score model overfitting led to inflated variance of estimated odds ratios.” Journal of clinical epidemiology 80: 97–106.
  • Schuster, Tibor, Menglan Pang, and Robert W Platt. 2015. “On the role of marginal confounder prevalence–implications for the high-dimensional propensity score algorithm.” Pharmacoepidemiology and drug safety 24 (9): 1004–1007.
  • Shortreed, Susan M, and Ashkan Ertefaie. 2017. “Outcome-adaptive lasso: variable selection for causal inference.” Biometrics 73 (4): 1111–1122.
  • Simoneau, Gabrielle, Fabio Pellegrini, Thomas PA Debray, Julie Rouette, Johanna Muñoz, Robert W Platt, John Petkau, et al. 2022. “Recommendations for the use of propensity score methods in multiple sclerosis research.” Multiple Sclerosis Journal 28 (9): 1467–1480.
  • Suarez, Elizabeth A, Michael Nguyen, Di Zhang, Yueqin Zhao, Danijela Stojanovic, Monica Munoz, Jane Liedtka, et al. 2023. “Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.” Pharmacoepidemiology and Drug Safety 32 (2): 126–136.
  • Tazare, John, Liam Smeeth, Stephen JW Evans, Ian J Douglas, and Elizabeth J Williamson. 2023. “hdps: A suite of commands for applying high-dimensional propensity-score approaches.” The Stata Journal 23 (3): 683–708.
  • Tazare, John, Liam Smeeth, Stephen JW Evans, Elizabeth Williamson, and Ian J Douglas. 2020. “Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records.” Pharmacoepidemiology and Drug Safety 29 (11): 1373–1381.
  • Tazare, John, Richard Wyss, Jessica M Franklin, Liam Smeeth, Stephen JW Evans, Shirley V Wang, Sebastian Schneeweiss, Ian J Douglas, Joshua J Gagne, and Elizabeth J Williamson. 2022. “Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting.” Pharmacoepidemiology and Drug Safety 31 (4): 411–423.
  • Thurin, Nicolas H, Magali Rouyer, Jérémy Jové, Marine Gross-Goupil, Thibaud Haaser, Xavier Rébillard, Michel Soulié, et al. 2022. “Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database.” Expert Review of Clinical Pharmacology 15 (9): 1139–1145.
  • Tian, Yuxi, Martijn J Schuemie, and Marc A Suchard. 2018. “Evaluating large-scale propensity score performance through real-world and synthetic data experiments.” International journal of epidemiology 47 (6): 2005–2014.
  • VanderWeele, Tyler J. 2019. “Principles of confounder selection.” European journal of epidemiology 34: 211–219.
  • Von Korff, Michael, Edward H Wagner, and Kathleen Saunders. 1992. “A chronic disease score from automated pharmacy data.” Journal of clinical epidemiology 45 (2): 197–203.
  • Weberpals, Janick, Tim Becker, Jessica Davies, Fabian Schmich, Dominik Rüttinger, Fabian J Theis, and Anna Bauer-Mehren. 2021. “Deep learning-based propensity scores for confounding control in comparative effectiveness research: A large-scale, real-world data study.” Epidemiology 32 (3): 378–388.
  • Whitcomb, Brian W, and Ashley I Naimi. 2021. “Defining, quantifying, and interpreting “noncollapsibility” in epidemiologic studies of measures of “effect”.” American Journal of Epidemiology 190 (5): 697.
  • Wyss, Richard, Bruce Fireman, Jeremy A Rassen, and Sebastian Schneeweiss. 2018a. “Erratum: high-dimensional propensity score adjustment in studies of treatment effects using health care claims data.” Epidemiology 29 (6): e63–e64.
  • Wyss, Richard, Sebastian Schneeweiss, Mark Van Der Laan, Samuel D Lendle, Cheng Ju, and Jessica M Franklin. 2018b. “Using super learner prediction modeling to improve high-dimensional propensity score estimation.” Epidemiology 29 (1): 96–106.
  • Wyss, Richard, Chen Yanover, Tal El-Hay, Dimitri Bennett, Robert W Platt, Andrew R Zullo, Grammati Sari, et al. 2022. “Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.” Pharmacoepidemiology and Drug Safety 31 (9): 932–943.
  • Yusuf, FLA, TS Tang, and ME Karim. 2022. “The association between diabetes and excessive daytime sleepiness among American adults aged 20–79 years: findings from the 2015–2018 National Health and Nutrition Examination Surveys.” Annals of Epidemiology 68: 54–63.
  • Zeileis, Achim, Susanne Köll, and Nathaniel Graham. 2020. “Various versatile variances: an object-oriented implementation of clustered covariances in R.” Journal of Statistical Software 95: 1–36.
  • Zhao, Qingyuan, Dylan S Small, and Bhaswar B Bhattacharya. 2019. “Sensitivity analysis for inverse probability weighting estimators via the percentile bootstrap.” Journal of the Royal Statistical Society Series B: Statistical Methodology 81 (4): 735–761.
  • Zhong, Y, EH Kennedy, LM Bodnar, and AI Naimi. 2021. “AIPW: an r package for augmented inverse probability–weighted estimation of average causal effects.” American Journal of Epidemiology 190 (12): 2690–2699.
  • Zivich, PN. 2021. “Publicly Available Code.” https://github.com/pzivich/publications-code.
  • Zivich, PN, and A Breskin. 2021. “Machine learning for causal inference: on the use of cross-fit estimators.” Epidemiology 32 (3): 393–401.
  • Zou, Hui, and Trevor Hastie. 2005. “Regularization and variable selection via the elastic net.” Journal of the Royal Statistical Society Series B: Statistical Methodology 67 (2): 301–320.